Charles Cazanave

Summary

Affiliation: CHU de Bordeaux
Country: France

Publications

  1. ncbi Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
    Charles Cazanave
    Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
    AIDS 22:395-402. 2008
  2. ncbi Candida prosthetic infections: case series and literature review
    Herve Dutronc
    Service de Maladies Infectieuses et Tropicales, Hopital Pellegrin, Universite Victor Segalen Bordeaux 2, CHU de Bordeaux, Bordeaux, France
    Scand J Infect Dis 42:890-5. 2010
  3. ncbi Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
    Frédéric Antoine Dauchy
    Services de Maladies Infectieuses et Tropicales and COREVIH, Hopital Pellegrin, CHU de Bordeaux, Université Bordeaux Segalen, Bordeaux, France
    Kidney Int 80:302-9. 2011
  4. ncbi Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008

Collaborators

Detail Information

Publications4

  1. ncbi Reduced bone mineral density in HIV-infected patients: prevalence and associated factors
    Charles Cazanave
    Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
    AIDS 22:395-402. 2008
    ..There is a high prevalence of bone demineralization among HIV-infected patients but mechanisms of alteration of bone turnover are still unclear and it is thought to be multifactorial...
  2. ncbi Candida prosthetic infections: case series and literature review
    Herve Dutronc
    Service de Maladies Infectieuses et Tropicales, Hopital Pellegrin, Universite Victor Segalen Bordeaux 2, CHU de Bordeaux, Bordeaux, France
    Scand J Infect Dis 42:890-5. 2010
    ..The benchmark antifungal therapies remain amphotericin B and/or fluconazole...
  3. ncbi Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
    Frédéric Antoine Dauchy
    Services de Maladies Infectieuses et Tropicales and COREVIH, Hopital Pellegrin, CHU de Bordeaux, Université Bordeaux Segalen, Bordeaux, France
    Kidney Int 80:302-9. 2011
    ..22) or had been discontinued (OR 11.49). Thus, cumulative exposure to TDF and/or atazanavir was associated with an increased risk of PRTD, with concern about its reversibility in patients with HIV...
  4. ncbi Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008
    ....